Acquired drug resistance is accompanied by modification in the karyotype and nuclear matrix of a rat carcinoma cell line.
A Walker 256 breast carcinoma cell line (WR) exhibiting a greater than 20-fold resistance to alkylating agents has been selected from a parent cell line (WS). Karyotypic heterogeneity was apparent, with a number of differences evident between WR and WS cells. The modal chromosome number for WS is 62; for WR, 54; double minutes were found only in WR, whereas spontaneous chromosomal aberrations were present in approx. 40% of the WS cells. No similar aberrations were observed in WR. Using SDS-gel electrophoresis and subsequent silver staining, differences in the profile of nuclear matrix proteins in WR and WS were observed. A diffuse band at approx. 70 kD in the WS was absent in WR cells. This protein was phosphorylated, together with a number of the other major matrix polypeptides. Levels of phosphorylated matrix proteins were approximately equivalent in both WR and WS cell lines, but matrix protein phosphorylation levels were approx. 2-fold higher than corresponding values for bulk nuclear proteins. Selective pressure of drug exposure has resulted in enhanced genetic stability in WR cells and observed karyotype differences are accompanied by modifications in the structural proteins of the nuclear matrix. Whether the observed differences are the cause or result of drug resistance remains to be established.
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy / Q000648:ultrastructure*; D002460:Cell Line; D002467:Cell Nucleus / Q000032:analysis*; D002699:Chlorambucil / Q000494:pharmacology*; D002869:Chromosome Aberrations; D002875:Chromosomes / Q000648:ultrastructure*; D004351:Drug Resistance; D007621:Karyotyping; D009363:Neoplasm Proteins / Q000032:analysis* / Q000378:metabolism; D010766:Phosphorylation; D051381:Rats
D009363:Neoplasm Proteins; D002699:Chlorambucil